R&D Sponsored Patentability and predictability in AI-assisted drug discove... Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.
Views & Analysis Improving trial predictability: leveraging AI-powered analyt... Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient popula
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.